Frost & Sullivan

Therapeutic Monoclonal Antibodies Market – Is Biologics the Answer to Rising Disease Incidence?

Existing adoption rates and commercial success of launched Monoclonal Antibodies (mAbs) for therapeutics have established a strong platform for these products. Broadening the horizontal indications for existing mAbs, expanding the applications of mAbs in new therapeutic areas and developing ... more

The Road Ahead for Biosimilars in Europe, Says Frost & Sullivan

The expiration of patents and other intellectual property rights of biological innovators over the next decade opens the opportunity for biosimilars to enter the market and increase industry competition. However, biosimilars manufacturers require heavy investments, which are a major barrier ... more

European Multiple Sclerosis Market in Dire Need of Increased Disease Awareness and Treatment Options, Cautions Frost & Sullivan

Limited awareness about the disease and its overall occurrence and progression among end-users is hampering the European multiple sclerosis (MS) market. This is being exacerbated by the limited availability of accurate diagnostic tools. There is, therefore, an immediate need for innovative ... more

Outsourcing to India and China: Cultural diffculties with the perception of costs

Aparna Singh (AS), Program Manager for the Chemicals Materials and Foods team at Frost & Sullivan India, recently caught up with Mr. Steve Fishwick (SF), Projects Group Director, AstraZeneca at the Frost & Sullivan's Global Life Sciences Summit 2006 at Goa, India. He was one of the key spea ... more

Wyeth 'learns and confirms' in India

Aparna Singh (AS), Program Manager with Frost & Sullivan's Chemical Materials and Foods team caught up with Dr. Michael Kolb (Dr. MK) at Frost & Sullivan's Opportunities in Lifescience Molecules: Global Partnership Summit 2006. This annual summit was held at Goa (India) from 21st -23rd May, ... more

Frost & Sullivan's Global PharmAlliance 2005: Becoming the Partner of Choice

Looking at the increasing trend towards partnerships and alliances in the pharmaceutical industry, Frost & Sullivan a global growth consulting company had organized a premium conference, "Global PharmAlliance 2005 - Becoming the partner of choice" in Mumbai (India). The two day event focuse ... more

Frost & Sullivan

Frost & Sullivan, an international consultancy firm, has been supporting clients' growth for over four decades. Our market expertise covers a broad spectrum of industries, while our portfolio of advisory competencies include strategic consultancy, market intelligence and management training. more